These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26426815)

  • 1. Photobiomodulation Mitigates Diabetes-Induced Retinopathy by Direct and Indirect Mechanisms: Evidence from Intervention Studies in Pigmented Mice.
    Saliba A; Du Y; Liu H; Patel S; Roberts R; Berkowitz BA; Kern TS
    PLoS One; 2015; 10(10):e0139003. PubMed ID: 26426815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-intensity far-red light inhibits early lesions that contribute to diabetic retinopathy: in vivo and in vitro.
    Tang J; Du Y; Lee CA; Talahalli R; Eells JT; Kern TS
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3681-90. PubMed ID: 23557732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photobiomodulation Inhibits Long-term Structural and Functional Lesions of Diabetic Retinopathy.
    Cheng Y; Du Y; Liu H; Tang J; Veenstra A; Kern TS
    Diabetes; 2018 Feb; 67(2):291-298. PubMed ID: 29167189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical and clinical studies of photobiomodulation therapy for macular oedema.
    Shen W; Teo KYC; Wood JPM; Vaze A; Chidlow G; Ao J; Lee SR; Yam MX; Cornish EE; Fraser-Bell S; Casson RJ; Gillies MC
    Diabetologia; 2020 Sep; 63(9):1900-1915. PubMed ID: 32661752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia.
    Li G; Tang J; Du Y; Lee CA; Kern TS
    Mol Vis; 2011; 17():3156-65. PubMed ID: 22171162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinylamine Benefits Early Diabetic Retinopathy in Mice.
    Liu H; Tang J; Du Y; Lee CA; Golczak M; Muthusamy A; Antonetti DA; Veenstra AA; Amengual J; von Lintig J; Palczewski K; Kern TS
    J Biol Chem; 2015 Aug; 290(35):21568-79. PubMed ID: 26139608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
    Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
    Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metanx and early stages of diabetic retinopathy.
    Liu H; Tang J; Lee CA; Kern TS
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(1):647-53. PubMed ID: 25574044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B; Sun JH; Xiang FF; Liu L; Li WJ
    Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.
    Kern TS; Miller CM; Du Y; Zheng L; Mohr S; Ball SL; Kim M; Jamison JA; Bingaman DP
    Diabetes; 2007 Feb; 56(2):373-9. PubMed ID: 17259381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.
    Liu Q; Zhang F; Zhang X; Cheng R; Ma JX; Yi J; Li J
    Mol Cell Biochem; 2018 Aug; 445(1-2):105-115. PubMed ID: 29264825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety Profile of Slit-Lamp-Delivered Retinal Laser Photobiomodulation.
    Ao J; Chidlow G; Wood JPM; Casson RJ
    Transl Vis Sci Technol; 2020 Mar; 9(4):22. PubMed ID: 32818109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes.
    Li J; Wang P; Ying J; Chen Z; Yu S
    Cell Physiol Biochem; 2016; 39(3):1196-208. PubMed ID: 27595397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of bestatin in the retina of streptozotocin-induced diabetic mice.
    Hossain A; Heron D; Davenport I; Huckaba T; Graves R; Mandal T; Muniruzzaman S; Wang S; Bhattacharjee PS
    Exp Eye Res; 2016 Aug; 149():100-106. PubMed ID: 27344955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of aldose reductase from mice inhibits diabetes-induced retinal capillary degeneration and superoxide generation.
    Tang J; Du Y; Petrash JM; Sheibani N; Kern TS
    PLoS One; 2013; 8(4):e62081. PubMed ID: 23614016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
    Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
    Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
    Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.
    Kanwar M; Chan PS; Kern TS; Kowluru RA
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3805-11. PubMed ID: 17652755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast Prevents Early Diabetic Retinopathy in Mice.
    Bapputty R; Talahalli R; Zarini S; Samuels I; Murphy R; Gubitosi-Klug R
    Diabetes; 2019 Oct; 68(10):2004-2015. PubMed ID: 31350303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.